Trial Profile
Investigation of antiproteinuric effect of paricalcitol in patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary)
- Indications Kidney disorders; Proteinuria
- Focus Therapeutic Use
- 05 Dec 2015 New trial record